Alpa Laboratories Ltd.

103.26 -1.59 ▼-1.5%

23 February 2024, 04:01:00 PM
Volume: 6,885

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.alpalabs.in
Market Cap 218.13 Cr.
Enterprise Value(EV) 219.69 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 8.55 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 12.13 Trailing Twelve Months Ending 2023-12
Industry PE 41.98 Trailing Twelve Months Ending 2023-12
Book Value / Share 70.26 Trailing Twelve Months Ending 2023-12
Price to Book Value 1.48 Calculated using Price: 103.67
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 2.10 Cr. 21,040,600 Shares
FaceValue 10
About Alpa Laboratories Ltd.
Alpa Laboratories, incorporated in 1988, is engaged in the business of manufacturing pharmaceutical products. In 1967, the company started its journey as a partnership concern with Purushottam R Patel, M S Chawla and Pravin C Shah as the founding partners. Later on March 18, 1988 the company became a private limited company and a decade later it became a public limited enterprise.

Alpa Laboratories Ltd. Delivery

Delivered Qty
Traded Qty

Alpa Laboratories Ltd. Performance

1 Day
-1.52%
1 Week
+1.58%
1 Month
-0.71%
3 Month
+2.25%
6 Month
+49.05%
1 Year
+74.43%
2 Year
+50.85%
5 Year
+331.15%
10 Year
+760.50%

Alpa Laboratories Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) -1.6 7.61 2.68 2.92 1.03 1.86 6.97 12.29 9.82
Return on Capital Employed (%) -0.89 9.61 6.59 5.47 3.26 3.09 10.42 16.81 12.19
Return on Assets (%) -1.1 4.99 1.86 2.29 0.84 1.54 5.56 9.53 7.8

Alpa Laboratories Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 87 93 95 98 98 100 108 122 135 143
Non Curr. Liab. 0 1 0 0 0 -1 0 5 3 2
Curr. Liab. 41 52 30 23 22 21 33 29 30 38
Minority Int.
Equity & Liab. 128 146 125 121 121 120 140 155 167 184
Non Curr. Assets 16 27 20 23 27 25 19 17 18 16
Curr. Assets 113 119 105 98 94 95 121 138 149 168
Misc. Exp. not W/O
Total Assets 128 146 125 121 121 120 140 155 167 184

Alpa Laboratories Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 57 54 63 63 78 86 98 112 93 114
Other Income 3 6 5 5 5 3 4 11 9 10
Total Income 61 59 69 68 83 89 102 123 102 125
Total Expenditure -55 -47 -56 -59 -77 -83 -90 -102 -85 -100
PBIDT 6 12 12 9 6 6 12 21 17 24
Interest -2 -1 -2 -1 -1 0 0 0 0 0
Depreciation -6 -1 -3 -3 -3 -3 -1 -2 -1 -2
Taxation 1 -3 -3 -2 -2 -1 -4 -5 -3 -4
Exceptional Items -1 -2 0
PAT -1 7 3 3 1 2 7 14 13 18
Minority Interest
Share Associate
Other Related Items
Consolidated Net Profit -1 7 3 3 1 2 7 14 13 18
Adjusted EPS -1 3 1 1 0 1 3 7 6 9

Alpa Laboratories Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 8 -2 -22 17 -13 -1 18 -2 10 9
Cash Fr. Inv. -2 37 -8 -2 -11 -15 -11 6 -16 2
Cash Fr. Finan. 4 7 -6 -15 9 -5 -1 0 5 -4
Net Change 10 42 -36 0 -15 -20 5 4 0 7
Cash & Cash Eqvt 10 53 17 37 21 1 6 11 2 9

Alpa Laboratories Ltd. Shareholding Pattern

9 Qtrs 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%)
Promoter 56.66 57.29 57.29 57.29 57.29 57.29 57.29 57.29 57.29
Public 43.34 42.71 42.71 42.71 42.71 42.71 42.71 42.71 42.71
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Alpa Laboratories Ltd. Announcements

Tue, 13 Feb 2024
Results For The Quarter Ended December 2023
Results for the Quarter ended December 2023
Thu, 01 Feb 2024
Board Meeting Intimation for To Consider The Financial Results For The Quarter Ended On 31St December 2023.
ALPA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2024 inter alia to consider and approve to consider the Financial Results for the Quarter ended on 31st December 2023.
Tue, 02 Jan 2024
Closure of Trading Window
Closure of Trading Window

Alpa Laboratories Ltd. Technical Scans

Fri, 23 Feb 2024
High Delivery Percentage High Delivery Percentage
Opening at High Opening at High
Closing Below Previous Low Closing Below Previous Low
Close Within 52 Week High Zone Close Within 52 Week High Zone
Opening at High for 2 Days Opening at High for 2 Days

Alpa Laboratories Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 374,572.18 1,560.95 +0.2%
Cipla Ltd. 118,375.92 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. 107,511.08 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. 97,345.81 6,742.15 -0.4%
Divi's Laboratories Ltd. 96,748.70 3,636.05 -0.3%
Zydus Lifesciences Ltd. 93,335.34 922.10 +1.9%
Torrent Pharmaceuticals Ltd. 88,913.00 2,627.10 +0.7%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 42.06 1,560.95 +0.2%
Cipla Ltd. Consolidated 2023-12 31.92 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 20.56 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 123.33 6,742.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-12 69.96 3,636.05 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-12 31.39 922.10 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 59.51 2,627.10 +0.7%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 6.00 1,560.95 +0.2%
Cipla Ltd. Consolidated 2023-12 4.57 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 4.00 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 14.41 6,742.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-12 7.42 3,636.05 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-12 4.80 922.10 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.43 2,627.10 +0.7%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,560.95 +0.2%
Cipla Ltd. Consolidated 2023-03 0.02 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,742.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,636.05 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 922.10 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,627.10 +0.7%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,560.95 +0.2%
Cipla Ltd. Consolidated 2023-03 12.85 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,742.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,636.05 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 922.10 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,627.10 +0.7%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,560.95 +0.2%
Cipla Ltd. Consolidated 2023-03 12.85 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,742.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,636.05 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 922.10 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,627.10 +0.7%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,560.95 +0.2%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,742.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,636.05 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 922.10 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,627.10 +0.7%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,560.95 +0.2%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,742.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,636.05 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 922.10 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,627.10 +0.7%

Alpa Laboratories Ltd. FAQ's

What is Alpa Lab share price?

Can I buy Alpa Lab shares now?

What is the Market Cap of Alpa Lab?

What are the key metrics to analyse Alpa Lab?

What is the 52 Week High and Low of Alpa Lab?

What is the trend of Alpa Lab share price?